![Jonathan Leitersdorf](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Leitersdorf
Director Ejecutivo en Famous NYC, Inc. .
Origen de la red de primer grado Jonathan Leitersdorf.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
LIVEKIDNEY.BIO
![]() LIVEKIDNEY.BIO Miscellaneous Commercial ServicesCommercial Services Kidneycure Ltd. develops cell therapies to prevent progression of chronic kidney diseases. The company was founded by Benjamin and Dekel Orit Harari-Steinberg and is headquartered in Tel Aviv, Israel.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jonathan Leitersdorf a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
X-Cell Medical, Inc.
![]() X-Cell Medical, Inc. Medical SpecialtiesHealth Technology X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ. | Medical Specialties | Chairman | |
Outcome Capital LLC
![]() Outcome Capital LLC Investment Banks/BrokersFinance Outcome Capital LLC is a life sciences and healthcare advisory and investment banking firm that specializes in providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering, and corporate finance. The firm was founded by Jonathan R. Wallace and is based in Boston, MA, with subsidiaries in the United States. The firm's multi-disciplinary team of industry experts draws from their broad relationships and a wide range of scientific, operational, strategic, and transactional expertise across the value chain to assist management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. | Investment Banks/Brokers | Founder | |
Neuroptics, Inc.
![]() Neuroptics, Inc. Medical SpecialtiesHealth Technology NeurOptics, Inc. provides neurological patient care services. It offers npi-100 pupillometer, an hand-held and cordless device that removes subjectivity in the measurement of pupil size and the pupillary light reflex. The company was founded by Kamran Siminou and is headquartered in Irvine, CA. | Medical Specialties | Chief Executive Officer | |
NEURODERM LTD | Biotechnology | Chief Executive Officer | |
Youdim Pharmaceuticals Ltd.
![]() Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel. | Investment Managers | Chief Executive Officer | |
Universitat Autònoma de Barcelona | College/University | Doctorate Degree | |
Clal Life Sciences (CLS) LP
![]() Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Investment Managers | Corporate Officer/Principal | |
XableCath, Inc.
![]() XableCath, Inc. Medical SpecialtiesHealth Technology XableCath, Inc. manufactures catheters for treatment of vascular diseases. The company was founded by Johannes B. Dahm and Lisa Jordan Dunlea in 2014 and is headquartered in Salt Lake City, UT. | Medical Specialties | Director/Board Member | |
University of Cambridge | College/University | Doctorate Degree | |
ELT Sight, Inc.
![]() ELT Sight, Inc. Managed Health CareHealth Services ELT Sight, Inc. engages in the provision of healthcare services. It focuses on micro-invasive glaucoma surgery. The company is headquartered in Los Angeles, CA. | Managed Health Care | Director/Board Member | |
Caliber Therapeutics, Inc.
![]() Caliber Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Caliber Therapeutics, Inc. is a holding company, which engages in the development of products for atherosclerotic diseases. It offers targeted angioplasty drug delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices. The company was founded on August 3, 2009 and is headquartered in New Hope, PA. | Pharmaceuticals: Major | Founder | |
Imperial College London | College/University | Undergraduate Degree | |
Oxford Bioscience Partners
![]() Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
University of Bradford | College/University | Masters Business Admin | |
The College of Management Academic Studies | College/University | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Israel | 6 |
Reino Unido | 4 |
España | 2 |
Sectorial
Health Technology | 8 |
Consumer Services | 6 |
Finance | 5 |
Health Services | 2 |
Operativa
Director/Board Member | 9 |
Chief Executive Officer | 5 |
Doctorate Degree | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Las relaciones más conectadas
Insiders | |
---|---|
Oded Ben-Joseph | 11 |
Alon Yaar | 8 |
Ran Avnat | 1 |
- Bolsa de valores
- Insiders
- Jonathan Leitersdorf
- Conexiones Empresas